Interventions for an Artemisinin-based Malaria Medicine Supply Chain

Burak Kazaz, Scott Webster, Prashant Yadav

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Artemisinin combination therapy, the most effective malaria treatment today, is manufactured from an agriculturally derived starting material Artemisia annua. Artemisinin, the main ingredient in malaria medicines, is extracted from Artemisia leaves and used in the production of medicine for treating malaria. The artemisinin market has witnessed high volatility in the supply and price of artemisinin extract. A large fraction of malaria medicines for endemic countries in sub-Saharan Africa is financed by the Global Fund to Fight AIDS, TB, and Malaria and the US President's Malaria Initiative. These agencies together with the World Health Organization, UNITAID, the United Kingdom Department for International Development and the Bill and Melinda Gates Foundation are exploring ways to increase the level of artemisinin production, reduce volatility of artemisinin prices, and improve overall access to malaria medicines for the population. We develop a model of the supply chain, calibrate the model using field data, and investigate the impact of various interventions. Our model shows that initiatives aimed at improving average yield, creating a support-price for agricultural artemisinin, and a larger and carefully managed supply of semi-synthetic artemisinin have the greatest potential for improving supply and reducing price volatility of artemisinin-based malaria medicine.

Original languageEnglish (US)
JournalProduction and Operations Management
DOIs
StateAccepted/In press - 2016

Fingerprint

Supply chains
Medicine
Malaria
Supply chain
Health

Keywords

  • Health care
  • Malaria
  • Supply and demand uncertainty

ASJC Scopus subject areas

  • Industrial and Manufacturing Engineering
  • Management Science and Operations Research
  • Management of Technology and Innovation

Cite this

Interventions for an Artemisinin-based Malaria Medicine Supply Chain. / Kazaz, Burak; Webster, Scott; Yadav, Prashant.

In: Production and Operations Management, 2016.

Research output: Contribution to journalArticle

@article{ef6d514f070545c0b15215436d997652,
title = "Interventions for an Artemisinin-based Malaria Medicine Supply Chain",
abstract = "Artemisinin combination therapy, the most effective malaria treatment today, is manufactured from an agriculturally derived starting material Artemisia annua. Artemisinin, the main ingredient in malaria medicines, is extracted from Artemisia leaves and used in the production of medicine for treating malaria. The artemisinin market has witnessed high volatility in the supply and price of artemisinin extract. A large fraction of malaria medicines for endemic countries in sub-Saharan Africa is financed by the Global Fund to Fight AIDS, TB, and Malaria and the US President's Malaria Initiative. These agencies together with the World Health Organization, UNITAID, the United Kingdom Department for International Development and the Bill and Melinda Gates Foundation are exploring ways to increase the level of artemisinin production, reduce volatility of artemisinin prices, and improve overall access to malaria medicines for the population. We develop a model of the supply chain, calibrate the model using field data, and investigate the impact of various interventions. Our model shows that initiatives aimed at improving average yield, creating a support-price for agricultural artemisinin, and a larger and carefully managed supply of semi-synthetic artemisinin have the greatest potential for improving supply and reducing price volatility of artemisinin-based malaria medicine.",
keywords = "Health care, Malaria, Supply and demand uncertainty",
author = "Burak Kazaz and Scott Webster and Prashant Yadav",
year = "2016",
doi = "10.1111/poms.12574",
language = "English (US)",
journal = "Production and Operations Management",
issn = "1059-1478",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Interventions for an Artemisinin-based Malaria Medicine Supply Chain

AU - Kazaz, Burak

AU - Webster, Scott

AU - Yadav, Prashant

PY - 2016

Y1 - 2016

N2 - Artemisinin combination therapy, the most effective malaria treatment today, is manufactured from an agriculturally derived starting material Artemisia annua. Artemisinin, the main ingredient in malaria medicines, is extracted from Artemisia leaves and used in the production of medicine for treating malaria. The artemisinin market has witnessed high volatility in the supply and price of artemisinin extract. A large fraction of malaria medicines for endemic countries in sub-Saharan Africa is financed by the Global Fund to Fight AIDS, TB, and Malaria and the US President's Malaria Initiative. These agencies together with the World Health Organization, UNITAID, the United Kingdom Department for International Development and the Bill and Melinda Gates Foundation are exploring ways to increase the level of artemisinin production, reduce volatility of artemisinin prices, and improve overall access to malaria medicines for the population. We develop a model of the supply chain, calibrate the model using field data, and investigate the impact of various interventions. Our model shows that initiatives aimed at improving average yield, creating a support-price for agricultural artemisinin, and a larger and carefully managed supply of semi-synthetic artemisinin have the greatest potential for improving supply and reducing price volatility of artemisinin-based malaria medicine.

AB - Artemisinin combination therapy, the most effective malaria treatment today, is manufactured from an agriculturally derived starting material Artemisia annua. Artemisinin, the main ingredient in malaria medicines, is extracted from Artemisia leaves and used in the production of medicine for treating malaria. The artemisinin market has witnessed high volatility in the supply and price of artemisinin extract. A large fraction of malaria medicines for endemic countries in sub-Saharan Africa is financed by the Global Fund to Fight AIDS, TB, and Malaria and the US President's Malaria Initiative. These agencies together with the World Health Organization, UNITAID, the United Kingdom Department for International Development and the Bill and Melinda Gates Foundation are exploring ways to increase the level of artemisinin production, reduce volatility of artemisinin prices, and improve overall access to malaria medicines for the population. We develop a model of the supply chain, calibrate the model using field data, and investigate the impact of various interventions. Our model shows that initiatives aimed at improving average yield, creating a support-price for agricultural artemisinin, and a larger and carefully managed supply of semi-synthetic artemisinin have the greatest potential for improving supply and reducing price volatility of artemisinin-based malaria medicine.

KW - Health care

KW - Malaria

KW - Supply and demand uncertainty

UR - http://www.scopus.com/inward/record.url?scp=84977562968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977562968&partnerID=8YFLogxK

U2 - 10.1111/poms.12574

DO - 10.1111/poms.12574

M3 - Article

JO - Production and Operations Management

JF - Production and Operations Management

SN - 1059-1478

ER -